Daewoong Pharmaceutical Co., Ltd.(KR:069620)
₩100,700.00-1200.00 (-1.18%)
KR:069620
Daewoong Pharmaceutical Co., Ltd. Revenue
₩100,700.00
At close:-1200.00 (-1.18%)
Want to see KR:069620 full AI Analyst Report?
Daewoong Pharmaceutical Co., Ltd. (069620) Revenue
Daewoong Pharmaceutical Co., Ltd. Revenue
Daewoong Pharmaceutical Co., Ltd. had a revenue of 459.42B in the quarter ending Sep 30, 2026, with 2.44%. This bring the company's revenue in the last twelve months to 1.68T, Increased 2.91%. In the fiscal year ending Dec 31, 2025, Daewoong Pharmaceutical Co., Ltd. had annual revenue of 1.57T with 10.42% growth.
- Revenue (ttm)
- 1.68T
- Revenue Growth
- 9.16%
- P/S Ratio
- 0.74
- Revenue/Employee
- KRW 875,633,295
- Employees
- 1,794
- Market Cap
- KRW 1.16T
Revenue Chart
Daewoong Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.57T | 148.20B | 10.42% |
| Dec 31, 2024 | 1.42T | 47.35B | 3.44% |
| Dec 31, 2023 | 1.38T | 95.24B | 7.44% |
| Dec 31, 2022 | 1.28T | 127.12B | 11.03% |
| Dec 31, 2021 | 1.15T | 97.55B | 9.24% |
| Dec 31, 2020 | 1.06T | -58.00B | -5.21% |
| Dec 31, 2019 | 1.11T | 82.00B | 7.95% |
| Dec 31, 2018 | 1.03T | 71.12B | 7.41% |
| Dec 31, 2017 | 960.31B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

